Intra-arterial infusions stand at the forefront of innovative medical interventions, serving as a strategic conduit for delivering specialized treatments directly to designated arteries. This advanced therapeutic approach involves the meticulous administration of medicinal compounds, ranging from potent drugs to imaging agents, directly into the arterial system. The distinctive advantage of intra-arterial infusions lies in their precision, enabling the concentration of therapeutic effects to a specific anatomical site. This targeted delivery mechanism not only enhances treatment efficacy but also minimizes the impact on the broader systemic circulation, paving the way for a more refined and personalized medical strategy. The integration of intra-arterial infusions is prominently featured in the realm of interventional medicine, where skilled practitioners harness its potential to address diverse medical conditions. Cancer treatments, in particular, benefit significantly from this technique, as it allows for the direct administration of chemotherapy drugs to the tumor site. Moreover, intra-arterial infusions find application in the realm of vascular disorders, contributing to the management of conditions such as arterial blockages or aneurysms.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States